Nanovaccine's rapid induction of anti-tumor immunity significantly improves malignant cancer immunotherapy
文献类型：期刊论文
| 作者 | Zhang, Ling-xiao2,3,4; Sun, Xia-mei2; Jia, Ying-bo2,3; Liu, Xiao-ge2,3; Dong, Mingdong1; Xu, Zhi Ping4; Liu, Rui-tian2 |
| 刊名 | NANO TODAY
 |
| 出版日期 | 2020-12-01 |
| 卷号 | 35页码:12 |
| ISSN号 | 1748-0132 |
| 关键词 | Malignant cancer immunotherapy Layered double hydroxide based nanovaccine Vaccination routes Quick induction of anti-tumor immunity |
| DOI | 10.1016/j.nantod.2020.100923 |
| 英文摘要 | The advantage of rapid tumor growth over slow immune induction often limits the efficiency of cancer therapeutic vaccines. Many functionalized micro-/nano-vaccines are shown to enhance cancer immunotherapy, but few studies correlate the therapeutic efficacy of these micro-/nano-vaccines to the vaccination route such as intravenous (IV), subcutaneous (SC) injection or their combination. Herein, we employed classical "priming + boosting" vaccination strategy to investigate the influence of four vaccination combinations (IV + IV, IV + SC, SC + IV and SC + SC) of nanovaccines on the anti-tumor therapeutic efficacy in mice bearing E.G7-OVA-lymphoma and B16F10-melanoma. The nanovaccines were constructed by loading antigen and CpG onto layered double hydroxide (LDH) nanoparticles. Our experimental data indicate that "IV-priming + SC-boosting" vaccination combination most efficiently inhibits the growth of early stage tumors, with the tumor volume reduced by >75-90 % in comparison with the control group. Based on these findings, a novel vaccination strategy, i.e. simultaneous IV and SC injection was proposed, which significantly delayed the progression of both early stage and advanced Bl6F10 tumors. Our current research for the first time correlates the vaccination route of nanovaccines to the anti-tumor therapeutic efficacy, and the highest efficacy of optimal vaccination combination (IV + SC) is benefited from that fact that IV priming quickly induces strong anti-tumor responses that are well sustained by subsequent SC boosting. Moreover, the simultaneous IV/SC vaccination potentially provides a novel vaccination strategy for enhanced immunotherapy of early stage and advanced tumors. (C) 2020 Elsevier Ltd. All rights reserved. |
| WOS关键词 | DOUBLE HYDROXIDE NANOPARTICLES ; DENDRITIC CELLS ; THERAPEUTIC VACCINES ; ADMINISTRATION ROUTE ; MELANOMA TUMOR ; CO-DELIVERY ; EXPRESSION ; EFFICIENT ; RESPONSES ; ADJUVANT |
| 资助项目 | International Partnership Program of Chinese Academy of Sciences[122111KYSB20180005] ; Australian Research Council (ARC)[DP170104643] ; Australian Research Council (ARC)[DP190103486] ; Danish National Research Foundation[904000219B] ; European Union[734174] ; UCAS Joint PhD Training Program[2018-23] |
| WOS研究方向 | Chemistry ; Science & Technology - Other Topics ; Materials Science |
| 语种 | 英语 |
| 出版者 | ELSEVIER SCI LTD |
| WOS记录号 | WOS:000600849700004 |
| 资助机构 | International Partnership Program of Chinese Academy of Sciences ; Australian Research Council (ARC) ; Danish National Research Foundation ; European Union ; UCAS Joint PhD Training Program |
| 源URL | [http://ir.ipe.ac.cn/handle/122111/43164]  |
| 专题 | 中国科学院过程工程研究所 |
| 通讯作者 | Xu, Zhi Ping; Liu, Rui-tian |
| 作者单位 | 1.Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Sino Danish Ctr Educ & Res SDC, DK-8000 Aarhus C, Denmark 2.Chinese Acad Sci, Inst Proc Engn, State Key Lab Biochem Engn, Beijing 100190, Peoples R China 3.Univ Chinese Acad Sci, Sch Chem Engn, Beijing 100049, Peoples R China 4.Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia |
| 推荐引用方式 GB/T 7714 | Zhang, Ling-xiao,Sun, Xia-mei,Jia, Ying-bo,et al. Nanovaccine's rapid induction of anti-tumor immunity significantly improves malignant cancer immunotherapy[J]. NANO TODAY,2020,35:12. |
| APA | Zhang, Ling-xiao.,Sun, Xia-mei.,Jia, Ying-bo.,Liu, Xiao-ge.,Dong, Mingdong.,...&Liu, Rui-tian.(2020).Nanovaccine's rapid induction of anti-tumor immunity significantly improves malignant cancer immunotherapy.NANO TODAY,35,12. |
| MLA | Zhang, Ling-xiao,et al."Nanovaccine's rapid induction of anti-tumor immunity significantly improves malignant cancer immunotherapy".NANO TODAY 35(2020):12. |
入库方式： OAI收割
来源：过程工程研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。